Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
clinical trials
fda
life sciences
national blog main
calcitonin gene-related peptide
chronic migraine
eli lilly
episodic migraine
indiana blog main
indiana top stories
national
san francisco blog main
san francisco top stories
teva pharmaceutical
abaloparatide
alder biopharmaceuticals
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
david rind
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
europe blog main
europe top stories
european commission
food and drug administration
fremanezumab
galcanezumab
indiana
institute for clinical and economic review
migraine
migraine research foundation
migraines
national top stories
What
approval
developed
3
×
drug
amgen
class
fda
medicines
migraine
new
nod
pain
starts
won
amgen’s
announced
approved
candidates
carries
decision
eli
europe
european
gets
head
headache
heart
late
lilly
marketing
marks
medicine
osteoporosis
prevent
preventive
raise
risk
thursday
warning
wins
Language
unset
Current search:
amgen
×
developed
×
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines